[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ECSP13012613A - Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol - Google Patents

Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol

Info

Publication number
ECSP13012613A
ECSP13012613A ECSP13012613A ECSP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A EC SP13012613 A ECSP13012613 A EC SP13012613A
Authority
EC
Ecuador
Prior art keywords
gosipol
copolymer
producing
carboximetilcellulose
sound
Prior art date
Application number
Other languages
English (en)
Inventor
Felix Ivanovich Ershov
Vladimir Georgievich Nesterenko
Abdushukur Abdukhalilovich Sarymsakov
Natalya Uryevna Alekseeva
Original Assignee
Ltd Liability Company Nearmedic Plus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ltd Liability Company Nearmedic Plus filed Critical Ltd Liability Company Nearmedic Plus
Publication of ECSP13012613A publication Critical patent/ECSP13012613A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/10Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
    • C08B11/12Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

La invención se refiere al campo de la química orgánica, la farmacología y la medicina y se refiere a un método para producir un copolímero de carboximetilcelulosa sódica y gosipol, que tiene la fórmula (I), así como también su uso en una terapia compleja para pacientes con trastornos del espectro autista y alteraciones cognitivas.
ECSP13012613 2010-10-11 2013-05-09 Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol ECSP13012613A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2010141697/05A RU2453559C1 (ru) 2010-10-11 2010-10-11 Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями

Publications (1)

Publication Number Publication Date
ECSP13012613A true ECSP13012613A (es) 2013-10-31

Family

ID=45938511

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP13012613 ECSP13012613A (es) 2010-10-11 2013-05-09 Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol

Country Status (26)

Country Link
US (1) US9078916B2 (es)
EP (1) EP2628754B8 (es)
JP (1) JP5690944B2 (es)
CN (1) CN103189393B (es)
AU (1) AU2011314406B2 (es)
BR (1) BR112013008888B1 (es)
CA (2) CA2896450A1 (es)
CL (2) CL2013000962A1 (es)
CO (1) CO6731081A2 (es)
CY (1) CY1119413T1 (es)
DK (1) DK2628754T3 (es)
EA (2) EA024810B1 (es)
EC (1) ECSP13012613A (es)
ES (1) ES2643167T3 (es)
GE (1) GEP201706607B (es)
HR (1) HRP20171330T1 (es)
HU (1) HUE034920T2 (es)
LT (1) LT2628754T (es)
PE (1) PE20140200A1 (es)
PL (1) PL2628754T3 (es)
PT (1) PT2628754T (es)
RS (1) RS56257B1 (es)
RU (1) RU2453559C1 (es)
SI (1) SI2628754T1 (es)
UA (2) UA108126C2 (es)
WO (1) WO2012050483A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2499002C1 (ru) * 2012-06-14 2013-11-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе
RU2577539C2 (ru) * 2014-06-17 2016-03-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе
RU2754067C2 (ru) * 2018-05-18 2021-08-25 Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение
RU2746504C1 (ru) * 2020-02-27 2021-04-14 Ниармедик Интернэшнл Лимитед Противомикробные средства на основе бета-глюканов, способы их получения и применения
JP7207364B2 (ja) 2020-05-19 2023-01-18 Jfeスチール株式会社 ロッドミルのロッド交換装置及び方法
CN114622407B (zh) * 2022-04-01 2023-09-19 浙江隆腾医用新材料有限公司 一种羧甲基纤维素钠纤维的洗脱方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2002755C1 (ru) * 1991-02-04 1993-11-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием
RU2222548C2 (ru) * 2000-07-21 2004-01-27 Зао "Ниармедик Плюс" Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе
AU2003247515A1 (en) * 2002-06-10 2003-12-22 Wyeth Novel formate salt of o-desmethyl-venlafaxine
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
RU2238122C1 (ru) * 2003-01-20 2004-10-20 Ооо "Ниармедик Плюс" Противоинфекционный фармацевтический препарат
RU2270708C1 (ru) * 2004-05-26 2006-02-27 Ооо "Ниармедик Плюс" Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний
US20060144723A1 (en) * 2004-11-02 2006-07-06 Mary Fuller Device for securing valuables
US20070003621A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Dosage forms for movement disorder treatment
US20090285865A1 (en) * 2008-05-14 2009-11-19 Shalaby Shalaby W Palatable, solid oral formulations for male chemical sterilization

Also Published As

Publication number Publication date
DK2628754T3 (da) 2017-11-20
HUE034920T2 (en) 2018-03-28
ES2643167T3 (es) 2017-11-21
CY1119413T1 (el) 2018-03-07
EA201390530A1 (ru) 2013-07-30
RU2010141697A (ru) 2012-04-20
RU2453559C1 (ru) 2012-06-20
US9078916B2 (en) 2015-07-14
JP5690944B2 (ja) 2015-03-25
PE20140200A1 (es) 2014-02-21
CO6731081A2 (es) 2013-08-15
LT2628754T (lt) 2017-11-10
EP2628754A1 (en) 2013-08-21
JP2013540866A (ja) 2013-11-07
US20130266534A1 (en) 2013-10-10
EA201690544A1 (ru) 2016-07-29
CL2013000962A1 (es) 2013-12-06
EA024810B1 (ru) 2016-10-31
CN103189393A (zh) 2013-07-03
CA2811583A1 (en) 2012-04-19
CA2896450A1 (en) 2012-04-19
PL2628754T3 (pl) 2017-12-29
BR112013008888A2 (pt) 2016-06-28
CL2015001180A1 (es) 2015-08-28
UA108975C2 (uk) 2015-06-25
EP2628754B1 (en) 2017-07-12
SI2628754T1 (en) 2017-11-30
PT2628754T (pt) 2017-10-19
AU2011314406B2 (en) 2016-08-11
EP2628754B8 (en) 2017-10-25
HRP20171330T1 (hr) 2017-10-20
AU2011314406A1 (en) 2013-05-23
EA031316B1 (ru) 2018-12-28
UA108126C2 (uk) 2015-03-25
EP2628754A4 (en) 2014-03-26
RS56257B1 (sr) 2017-11-30
WO2012050483A1 (ru) 2012-04-19
CA2811583C (en) 2016-03-22
BR112013008888B1 (pt) 2021-01-05
GEP201706607B (en) 2017-01-25
CN103189393B (zh) 2015-09-30

Similar Documents

Publication Publication Date Title
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
CR20140512A (es) Dispositivos y metodos para la fabricación de aditivos de componentes de implante
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
EA201171367A1 (ru) Винилиндазолильные соединения
TR201813877T4 (tr) Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler.
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
EA201400178A1 (ru) Лечение рака молочной железы
UY33735A (es) Compuestos antivirales
EA201490546A1 (ru) Замещенные аннелированные пиримидины и их применение
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
ECSP13012613A (es) Método para producir y usar un copolímero de carboximetilcelulosa sódica y gosipol
CU24263B1 (es) Derivados de imidazopiridazinas inhibidores de quinasa akt, útiles para el tratamiento del cáncer
CL2011002090A1 (es) Complejo de haluro de agomelatina, que corresponde a un derivado de naftaleno; procedimiento de preparacion del mismo.
FI20115135A (fi) Mikrofibrilloidun selluloosan tulehduksia estävä vaikutus
EA201200046A1 (ru) Новые соединения, фармацевтическая композиция и связанные с ними способы
MX2015014344A (es) Terapia contra el cancer.
GT201200345A (es) Compuestos heterocìclicos, su preparaciòn y su aplicaciòn terapèutica
ECSP14002542A (es) Nuevos 2h–indazoles como antagonistas del receptor ep2
DOP2015000176A (es) Compuestos de azetidiniloxifenilpirrolidina
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.
EA201590656A1 (ru) Азаиндолины
EA200970816A1 (ru) Новая лекарственная форма
CO6670518A2 (es) Tratamiento de infecciones de clostridium difícile en pacientes bajo terapia con antibióticos